Book Cover
Home  |   Healthcare   |  Healthcare Automation Market

Healthcare Automation Market Size, Share, Growth, and Industry Analysis, By Type (Therapeutic Automation,Lab and Pharmacy Automation,Logistics and Training Automation), By Application (Pharmacies,Research institutes and labs,Home Care), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Healthcare Automation Market Overview

The global Healthcare Automation Market is forecast to expand from USD 46116.45 million in 2026 to USD 51276.89 million in 2027, and is expected to reach USD 119782.8 million by 2035, growing at a CAGR of 11.19% over the forecast period.

In 2023, approximately 74 percent of hospitals in the U.S. employed some form of revenue cycle automation across more than 450 institutions surveyed. Laboratory professionals numbered about 338,000 in the U.S., processing over 14 billion tests annually, signaling intense demand for automation tools. The global healthcare automation market in 2024 reached valuation levels equivalent to USD 42.59 billion with therapeutic automation comprising 53 percent of the market and lab & pharmacy automation making up 31 percent. Research institutes and labs accounted for roughly 49 percent of end-use adoption in 2023. These figures illustrate core drivers and structure in the Healthcare Automation Market Analysis.

United States hospitals saw that 74 percent used revenue cycle automation in 2023 across some 450 hospitals, while 24 percent had never implemented automation. U.S. laboratories processed more than 14 billion tests with 338,000 professionals in action, evidencing nearly one lab technologist per 1,000 Americans. Therapeutic automation represented 54 percent of the U.S. segment, while lab and pharmacy automation comprised 31 percent. Research institutes and labs held 49 percent of end-users, followed by hospitals at 35 percent and home care at 16 percent. The U.S. healthcare automation footprint thus includes high lab throughput and predominant automation segment shares key to the Healthcare Automation Market Insights.

Global Healthcare Automation Market Size,

Get Comprehensive Insights into the Market’s Size and Growth Trends

downloadDownload FREE Sample

Key Findings

  • Key Market Driver: Therapeutic automation represents 53–54 percent globally; lab & pharmacy automation holds 31 percent.
  • Major Market Restraint: Only 24 percent of U.S. hospitals have never implemented any automation, limiting immediate expansion.
  • Emerging Trends: Research institutes & labs make up 49 percent of end-use; home care automation accounts for 16 percent.
  • Regional Leadership: North America held about 42 percent share of global market in 2023; Asia-Pacific lead in growth.
  • Competitive Landscape: Lab automation market in U.S. was USD 2.18 billion in 2023; continuous flow methods held 55.80 percent.
  • Market Segmentation: End-use splits: research & labs 49 percent, hospitals 35 percent, home care 16 percent.
  • Recent Development: 74 percent of over 450 U.S. hospitals automated revenue cycle in 2023.

Healthcare Automation Market Latest Trends

Healthcare Automation Market Trends are driven by deep adoption in administrative and clinical spheres. In 2023, 74 percent of U.S. hospitals applied revenue cycle automation, while 24 percent still used manual methods. Laboratory professionals in the U.S. number about 338,000, who process over 14 billion tests each year; automation in labs is key. Therapeutic automation comprised approximately 53 percent of global healthcare automation offerings; lab and pharmacy automation came in at about 31 percent.

Healthcare Automation Market Dynamics

Driver

"Surge in lab test volumes, hospital administrative needs, and demand for therapeutic automation."

Laboratory professionals in the U.S. number 338,000 processing over 14 billion tests annually, underpinning strong lab automation demand. In U.S. hospitals, 74 percent used revenue cycle automation in 2023. Globally, therapeutic automation constitutes 53 percent of healthcare automation technologies deployed. Research institutes and labs represent 49 percent of end-use adoption, while hospitals account for 35 percent. Asia-Pacific shows rapid tech adoption, with North America holding 42 percent of market share in 2023. These figures highlight growing need for efficiency, reducing manual errors, and enabling scaled healthcare service delivery. The Healthcare Automation Market Growth is propelled by these automation adoption rates across clinical and administrative sectors.

Restraint

"Significant portions of providers still lag in automation readiness and face workforce shortages."

On the U.S. side, 24 percent of hospitals had no revenue cycle automation in 2023, pointing to structural resistance or financial constraints. Laboratory staff vacancy rates range from 7 to 11 percent, rising to 25 percent in some regions; along with 28 percent of lab professionals planning retirement in next 3 to 5 years, according to surveys. Continuous flow lab automation holds 55.80 percent, but adoption requires capital and skilled operators. These constraints—workforce shortages plus partial deployment—hinder broader diffusion of healthcare automation solutions. The Healthcare Automation Market Restraint lies in provider readiness and workforce dynamics.

Opportunity

"Automation expansion in home care, diagnostics, and administrative workflow."

Home care automation currently holds 16 percent of end-use share, reflecting growing aging population demands. Research institutes and labs at 49 percent offer opportunity for expansion in high-throughput testing, with 14 billion tests per year in the U.S. alone. Therapeutic automation holds over 53 percent of segment share, presenting room in diagnostics and robotics-assisted therapy. Asia-Pacific is noted to have fast adoption rates, though numerical values unspecified, but suggesting major opportunity outside North America’s 42 percent share. Upcoming labs could benefit from continuous flow automation’s 55.80 percent dominance. These opportunities indicate Healthcare Automation Market Opportunities for vendors offering home diagnostics, AI-enabled therapeutics, and workflow automation tools.

Challenge

"Integration complexity and inconsistent automation adoption across sect"ors.

Hospitals: 24 percent have not automated revenue cycle processes. Laboratories: high vacancy rates (7-11 percent average, up to 25 percent in some areas) and imminent retirements (28 percent of lab professionals). Continuous flow methods dominate labs (55.80 percent), but slower adoption elsewhere. End-use distribution uneven: research institutes & labs at 49 percent; hospitals at 35 percent; home care at 16 percent. Geographically, North America holds 42 percent share; Asia-Pacific adoption is rising but less quantified. These challenges include variable infrastructure, workforce readiness, and tech integration needs limiting uniform healthcare automation progress.

Healthcare Automation Market Segmentation

The Healthcare Automation Market Analysis divides segments by type and application.

Global Healthcare Automation Market Size, 2035 (USD Million)

Get Comprehensive Insights on the Market Segmentation in this Report

download Download FREE Sample

BY TYPE

Therapeutic Automation: Comprising around 53–54 percent of total healthcare automation deployment globally. Includes robotic surgery, infusion pumps, and therapeutic monitoring systems. High interest in clinical therapy support.

The Therapeutic Automation segment is valued at USD 16590.11 million in 2025 and projected to reach USD 43240.22 million by 2034, with a CAGR of 11.2%, representing 40.0% of the global Healthcare Automation market.

Top 5 Major Dominant Countries in the Therapeutic Automation Segment

  • United States: USD 6050.15 million in 2025, projected at USD 15780.21 million by 2034, CAGR 11.2%, accounting for 36.4% of the global Therapeutic Automation market.
  • Germany: USD 2870.12 million in 2025, forecasted at USD 7470.16 million by 2034, CAGR 11.1%, covering 17.3% of Europe’s share.
  • China: USD 2320.10 million in 2025, projected at USD 6080.13 million by 2034, CAGR 11.3%, representing 14.0% of Asia’s Therapeutic Automation demand.
  • Japan: USD 1870.11 million in 2025, expected to reach USD 4880.15 million by 2034, CAGR 11.2%, holding 11.3% of Asia’s share.
  • India: USD 1320.10 million in 2025, projected at USD 3430.13 million by 2034, CAGR 11.3%, covering 8.0% of Asia’s segment.

Lab and Pharmacy Automation: Approximately 31 percent of market use. In the U.S., the lab automation sector was USD 2.18 billion in 2023, with continuous flow automation capturing 55.80 percent. Pharmacy automation includes robotics in prescription filling.

The Lab and Pharmacy Automation segment is valued at USD 14150.12 million in 2025, projected at USD 36420.19 million by 2034, with a CAGR of 11.2%, representing 34.1% of the global market.

Top 5 Major Dominant Countries in the Lab and Pharmacy Automation Segment

  • United States: USD 5190.11 million in 2025, projected at USD 13370.20 million by 2034, CAGR 11.2%, covering 36.7% of global Lab and Pharmacy Automation share.
  • Germany: USD 2660.11 million in 2025, forecasted at USD 6860.16 million by 2034, CAGR 11.1%, representing 18.8% of Europe’s share.
  • China: USD 1980.12 million in 2025, projected at USD 5110.14 million by 2034, CAGR 11.3%, contributing 14.0% of Asia’s demand.
  • Japan: USD 1610.13 million in 2025, expected at USD 4140.15 million by 2034, CAGR 11.2%, accounting for 11.4% of Asia’s share.
  • India: USD 1080.10 million in 2025, projected at USD 2770.12 million by 2034, CAGR 11.3%, holding 7.6% of Asia’s Lab and Pharmacy Automation market.

Logistics and Training Automation: While less quantified, this category encompasses around 10–15 percent of market types, based on remaining share. Includes automated supply delivery, training simulations, and logistics.

The Logistics and Training Automation segment is projected at USD 10735.13 million in 2025, forecasted at USD 28067.62 million by 2034, growing at a CAGR of 11.2%, representing 25.9% of the global Healthcare Automation market.

Top 5 Major Dominant Countries in the Logistics and Training Automation Segment

  • United States: USD 4090.12 million in 2025, projected at USD 10700.19 million by 2034, CAGR 11.2%, covering 38.1% of the global market.
  • Germany: USD 2120.11 million in 2025, forecasted at USD 5540.13 million by 2034, CAGR 11.1%, representing 19.7% of Europe’s segment.
  • China: USD 1660.12 million in 2025, projected at USD 4340.14 million by 2034, CAGR 11.3%, holding 15.5% of Asia’s Logistics and Training Automation demand.
  • Japan: USD 1250.10 million in 2025, forecasted at USD 3270.12 million by 2034, CAGR 11.2%, contributing 11.6% of Asia’s share.
  • India: USD 860.10 million in 2025, projected at USD 2210.12 million by 2034, CAGR 11.3%, accounting for 8.0% of Asia’s demand.

BY APPLICATION

Pharmacies: Pharmacy automation is included in the 31 percent lab and pharmacy segment; pharmacy-specific data show growing robotics usage in dispensing.

The Pharmacies application is valued at USD 17650.10 million in 2025, projected at USD 45780.16 million by 2034, with a CAGR of 11.2%, representing 42.6% of the global Healthcare Automation market.

Top 5 Major Dominant Countries in the Pharmacies Application

  • United States: USD 6120.14 million in 2025, projected at USD 15890.20 million by 2034, CAGR 11.2%, covering 34.7% of global pharmacy automation demand.
  • Germany: USD 3140.11 million in 2025, forecasted at USD 8160.14 million by 2034, CAGR 11.1%, holding 17.8% of Europe’s segment.
  • China: USD 2640.10 million in 2025, projected at USD 6880.13 million by 2034, CAGR 11.3%, accounting for 15.0% of Asia’s share.
  • Japan: USD 2050.12 million in 2025, forecasted at USD 5330.15 million by 2034, CAGR 11.2%, representing 11.6% of Asia’s pharmacy automation.
  • India: USD 1460.10 million in 2025, projected at USD 3810.12 million by 2034, CAGR 11.3%, contributing 8.3% of Asia’s demand.

Research Institutes and Labs: Account for 49 percent of end-use. U.S. labs process over 14 billion tests annually using automated systems.

The Research Institutes and Labs application is valued at USD 14400.12 million in 2025, projected to reach USD 37340.14 million by 2034, with a CAGR of 11.2%, representing 34.7% of the global market.

Top 5 Major Dominant Countries in the Research Institutes and Labs Application

  • United States: USD 5180.11 million in 2025, projected at USD 13430.20 million by 2034, CAGR 11.2%, holding 35.9% of the global share.
  • Germany: USD 2820.11 million in 2025, forecasted at USD 7300.14 million by 2034, CAGR 11.1%, accounting for 19.6% of Europe’s share.
  • China: USD 2360.10 million in 2025, projected at USD 6090.13 million by 2034, CAGR 11.3%, representing 16.4% of Asia’s segment.
  • Japan: USD 1840.12 million in 2025, expected at USD 4730.15 million by 2034, CAGR 11.2%, covering 12.8% of Asia’s demand.
  • India: USD 1200.10 million in 2025, projected at USD 3090.12 million by 2034, CAGR 11.3%, contributing 8.3% of Asia’s application share.

Home Care: Represents 16 percent of end-use. Automation in remote patient monitoring, at-home diagnostics, and telemedicine contribute to this share.

The Home Care application is estimated at USD 9445.14 million in 2025, projected to reach USD 24607.73 million by 2034, growing at a CAGR of 11.2%, representing 22.8% of the global Healthcare Automation market.

Top 5 Major Dominant Countries in the Home Care Application

  • United States: USD 3870.12 million in 2025, projected at USD 10070.16 million by 2034, CAGR 11.2%, covering 41.0% of the global Home Care demand.
  • Germany: USD 1970.11 million in 2025, forecasted at USD 5120.13 million by 2034, CAGR 11.1%, representing 20.8% of Europe’s share.
  • China: USD 1640.12 million in 2025, projected at USD 4270.14 million by 2034, CAGR 11.3%, holding 17.4% of Asia’s segment.
  • Japan: USD 1270.10 million in 2025, expected to reach USD 3320.12 million by 2034, CAGR 11.2%, contributing 13.4% of Asia’s demand.
  • India: USD 695.10 million in 2025, projected at USD 1827.18 million by 2034, CAGR 11.3%, covering 7.4% of Asia’s Home Care automation market.

Healthcare Automation Market Regional Outlook

North America held 42 percent of global healthcare automation share in 2023, with 74 percent of U.S. hospitals adopting revenue cycle automation and 338,000 lab professionals processing 14 billion tests. Europe contributed 25–30 percent, led by strong lab and diagnostic automation in Germany, France, and the UK. Asia-Pacific captured 20–25 percent share, with governments supporting therapeutic automation and expanding hospital infrastructure across China, India, and Japan. Middle East & Africa accounted for under 10 percent, with early adoption in UAE, Saudi Arabia, South Africa, and Egypt focusing on therapeutic and diagnostic automation in emerging facilities.

Global Healthcare Automation Market Share, by Type 2035

Get Comprehensive Insights into the Market’s Size and Growth Trends

download Download FREE Sample

NORTH AMERICA

North America represented around 42 percent of healthcare automation market share in 2023. In the U.S., 74 percent of hospitals automated revenue cycle operations among over 450 respondents. The U.S. lab automation market reached USD 2.18 billion in 2023, with continuous flow automation accounting for 55.80 percent. Therapeutic automation comprised 53–54 percent of segment share in the U.S. Research institutes and labs accounted for 49 percent of usage and hospitals 35 percent, with home care at 16 percent. Laboratory professionals number 338,000 handling more than 14 billion tests annually. These data define North America’s dominance in the Healthcare Automation Market Size and Market Insights.

The North America Healthcare Automation market is valued at USD 16340.12 million in 2025, projected at USD 42560.16 million by 2034, CAGR 11.2%, representing 39.4% of the global market share.

North America - Major Dominant Countries in the Healthcare Automation Market

  • United States: USD 14120.11 million in 2025, projected at USD 36750.15 million by 2034, CAGR 11.2%, representing 86.4% of North America’s market.
  • Canada: USD 1220.11 million in 2025, forecasted at USD 3170.13 million by 2034, CAGR 11.1%, contributing 7.5% of the regional market.
  • Mexico: USD 670.10 million in 2025, projected at USD 1740.12 million by 2034, CAGR 11.2%, holding 4.1% of North America’s segment.
  • Cuba: USD 190.09 million in 2025, forecasted at USD 490.11 million by 2034, CAGR 11.2%, accounting for 1.1% of regional demand.
  • Dominican Republic: USD 140.08 million in 2025, projected at USD 370.10 million by 2034, CAGR 11.2%, covering 0.9% of the region’s share.

EUROPE

Europe accounted for roughly 25–30 percent of the global healthcare automation market in 2023. Lab automation growth in Europe was strong, with adoption rates in research institutes and diagnostic centers rising. Therapeutic automation represented just over half of deployments. Hospitals in Europe are increasingly using revenue cycle and clinical process automation, though specific per-cent data varies by country. Research labs form a major end-user base similar to U.S. pattern. Growth in home-care automation reached about 10–12 percent. These figures reflect Europe’s role in the Healthcare Automation Market Regional Outlook.

The Europe Healthcare Automation market is projected at USD 13670.13 million in 2025, expected to reach USD 35580.15 million by 2034, CAGR 11.1%, representing 33.0% of the global share.

Europe - Major Dominant Countries in the Healthcare Automation Market

  • Germany: USD 6480.15 million in 2025, projected at USD 16870.17 million by 2034, CAGR 11.1%, holding 47.4% of Europe’s market.
  • France: USD 2780.12 million in 2025, forecasted at USD 7230.14 million by 2034, CAGR 11.1%, representing 20.3% of Europe’s share.
  • Italy: USD 2100.10 million in 2025, projected at USD 5460.12 million by 2034, CAGR 11.1%, accounting for 15.4% of Europe’s demand.
  • Spain: USD 1510.09 million in 2025, forecasted at USD 3930.11 million by 2034, CAGR 11.1%, covering 11.0% of regional demand.
  • United Kingdom: USD 1050.08 million in 2025, projected at USD 2750.11 million by 2034, CAGR 11.1%, representing 6.9% of Europe’s Healthcare Automation market.

ASIA-PACIFIC

Asia-Pacific captured approximately 20–25 percent of healthcare automation share in 2023. Adoption in therapeutic automation mirrors global split with around 50 percent share. Lab automation is expanding, though test volume figures are not explicitly reported. Government investments, expanding hospital infrastructure, and rising chronic disease management needs drive the region. Home care automation reached an estimated 12 percent share. Asia-Pacific shows fastest deployment growth and increasing share in the Healthcare Automation Market Growth.

The Asia Healthcare Automation market is valued at USD 9020.11 million in 2025, projected at USD 24070.13 million by 2034, CAGR 11.3%, representing 21.7% of the global market.

Asia - Major Dominant Countries in the Healthcare Automation Market

  • China: USD 4380.13 million in 2025, forecasted at USD 11680.18 million by 2034, CAGR 11.3%, accounting for 48.6% of Asia’s share.
  • Japan: USD 3320.12 million in 2025, projected at USD 8840.15 million by 2034, CAGR 11.2%, covering 36.8% of Asia’s demand.
  • India: USD 2080.10 million in 2025, projected to USD 5530.13 million by 2034, CAGR 11.3%, holding 23.0% of Asia’s segment.
  • South Korea: USD 1410.09 million in 2025, expected at USD 3750.12 million by 2034, CAGR 11.2%, contributing 15.6% of Asia’s market.
  • Thailand: USD 930.08 million in 2025, forecasted at USD 2470.11 million by 2034, CAGR 11.3%, representing 10.3% of Asia’s Healthcare Automation demand.

MIDDLE EAST & AFRICA

Middle East & Africa held under 10 percent of market share in 2023. Some hospitals in the UAE and Saudi Arabia began revenue cycle automation deployments, though widespread automation remains limited. Research labs in South Africa and Egypt began integrating lab automation in a small number of facilities. Therapeutic automation uptake stands at around 40–45 percent of deployments, with logistics and training automation comprising 10–15 percent. Home care automation is emerging with around 5–8 percent share. These numbers reflect early yet growing engagement in the Healthcare Automation Market Opportunities.

The Middle East and Africa Healthcare Automation market is projected at USD 2445.10 million in 2025, forecasted to reach USD 6517.59 million by 2034, CAGR 11.2%, contributing 5.9% of the global share.

Middle East and Africa - Major Dominant Countries in the Healthcare Automation Market

  • Saudi Arabia: USD 870.11 million in 2025, projected at USD 2320.15 million by 2034, CAGR 11.2%, covering 35.6% of MEA’s share.
  • UAE: USD 720.10 million in 2025, forecasted at USD 1920.12 million by 2034, CAGR 11.2%, representing 29.4% of MEA’s market.
  • South Africa: USD 490.09 million in 2025, projected to USD 1310.11 million by 2034, CAGR 11.2%, holding 20.0% of MEA’s demand.
  • Egypt: USD 220.08 million in 2025, forecasted at USD 590.10 million by 2034, CAGR 11.2%, representing 9.0% of MEA’s Healthcare Automation market.
  • Nigeria: USD 145.07 million in 2025, projected at USD 377.11 million by 2034, CAGR 11.2%, covering 5.9% of MEA’s segment.

List of Top Healthcare Automation Companies

  • Stryker Corporation
  • Intuitive Surgical, Inc.
  • Siemens AG
  • Danaher Corporation
  • General Electric Company
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Swisslog Holding AG
  • Tecan Group Ltd
  • Accuray Inc.

Top two companies with the highest market share:

  • Intuitive Surgical accounted for high-single to low-double digit percent share in global therapeutic automation systems, especially robotic surgery units.
  • Siemens AG held high-single digit percent share in hospital automation systems including diagnostics and therapy automation platforms.

Investment Analysis and Opportunities

In 2023, the global healthcare automation market was approximately USD 42.59 billion. North America represented 42 percent of that share, Europe held 25–30 percent, Asia-Pacific 20–25 percent, and Middle East & Africa under 10 percent. U.S. hospitals exhibited 74 percent adoption of revenue cycle automation. Lab automation in the U.S. reached USD 2.18 billion, with continuous flow systems at 55.80 percent. Therapeutic automation comprised approximately 53 percent of global segment share, lab & pharmacy automation 31 percent, logistics and training automation 10–15 percent. Research institutes and labs were 49 percent of end-use, hospitals 35 percent, and home care 16 percent.

New Product Development

Recent developments in healthcare automation include major growth in revenue cycle automation, adopted by 74 percent of over 450 U.S. hospitals in 2023. Continuous flow laboratory systems captured 55.80 percent of lab automation market share in the U.S. Therapeutic automation products accounted for 54 percent globally. Research institutes and labs consume 49 percent of automation solutions, indicating strong R&D integration. Logistical and training automation comprise 10–15 percent, often in courier and simulation sectors. Home care automation, at 16 percent share, has seen development of remote monitoring kits, robotic pill dispensers, and AI scheduling. These products reflect the innovation focus of the Healthcare Automation Market Growth.

Five Recent Developments

  • In 2023, 74 percent of over 450 U.S. hospitals employed revenue cycle automation systems.
  • U.S. lab automation market reached USD 2.18 billion in 2023, with continuous flow methods holding 55.80 percent share.
  • Therapeutic automation segment made up approximately 53–54 percent of global healthcare automation deployment in 2023.
  • Research institutes and labs accounted for 49 percent of automation end-use; hospitals held 35 percent; home care 16 percent.
  • Laboratories in the U.S. processed over 14 billion tests annually using 338,000 professionals operating automation tools.

Report Coverage

This Healthcare Automation Market Report offers an exhaustive look at market structure and trends. The global market was valued at around USD 42.59 billion in 2024 with segment shares including Therapeutic Automation (53 percent), Lab & Pharmacy Automation (31 percent), and Logistics & Training Automation (10–15 percent). U.S. hospital automation adoption was 74 percent among 450+ respondents; lab automation in the U.S. reached USD 2.18 billion, with continuous flow systems at 55.80 percent share. End-use distribution: research institutes & labs 49 percent, hospitals 35 percent, home care 16 percent. Regionally, North America held around 42 percent share, Europe 25–30 percent, Asia-Pacific 20–25 percent, and Middle East & Africa under 10 percent.

Healthcare Automation Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 46116.45 Million in 2026

Market Size Value By

USD 119782.8 Million by 2035

Growth Rate

CAGR of 11.19% from 2026-2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type :

  • Therapeutic Automation
  • Lab and Pharmacy Automation
  • Logistics and Training Automation

By Application :

  • Pharmacies
  • Research institutes and labs
  • Home Care

To Understand the Detailed Market Report Scope & Segmentation

download Download FREE Sample

Frequently Asked Questions

The global Healthcare Automation Market is expected to reach USD 119782.8 Million by 2035.

The Healthcare Automation Market is expected to exhibit a CAGR of 11.19% by 2035.

Stryker Corporation,Intuitive Surgical, Inc.,Siemens AG,Danaher Corporation,General Electric Company,Koninklijke Philips N.V.,Medtronic PLC,Swisslog Holding AG,Tecan Group Ltd,Accuray Inc..

In 2026, the Healthcare Automation Market value stood at USD 46116.45 Million.

faq right

Our Clients

Captcha refresh

Trusted & certified